Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

H. R. Mortensen; P. Populaire; L. Hoffmann; D. S. Moeller; A. Appelt; P. Nafteux; C. T. Muijs; C. Grau; M. A. Hawkins; E. G.C. Troost; G. Defraene; R. Canters; C. S. Clarke; D. C. Weber; E. W. Korevaar; K. Haustermans; M. Nordsmark; Val Gebski; M. P. Achiam; Sheraz R. Markar; Ganesh Radhakrishna; Maaike Berbee; Daniele Scartoni; Ester Orlandi; Jerome Doyen; Vincent Gregoire; Gilles Crehange; Johannes Langendijk; Paula Lorgelly; Hedwig M. Blommestein; Camilla S. Byskov; Mai L. Ehmsen; Maria Fuglsang Jensen; Gloria Vilches Freixas; Rebecca Bütoft; The PROTECT consortium

doi:10.1016/j.radonc.2023.109980

Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

H. R. Mortensen, P. Populaire, L. Hoffmann, D. S. Moeller, A. Appelt, P. Nafteux, C. T. Muijs, C. Grau, M. A. Hawkins, E. G.C. Troost, G. Defraene, R. Canters, C. S. Clarke, D. C. Weber, E. W. Korevaar, K. Haustermans, M. Nordsmark, Val Gebski, M. P. Achiam, Sheraz R. MarkarGanesh Radhakrishna, Maaike Berbee, Daniele Scartoni, Ester Orlandi, Jerome Doyen, Vincent Gregoire, Gilles Crehange, Johannes Langendijk, Paula Lorgelly, Hedwig M. Blommestein, Camilla S. Byskov, Mai L. Ehmsen, Maria Fuglsang Jensen, Gloria Vilches Freixas, Rebecca Bütoft, The PROTECT consortium

Health Technology Assessment (HTA)

Research output: Contribution to journal › Editorial › Academic › peer-review

2 Citations (Scopus)

Original language	English
Article number	109980
Journal	Radiotherapy and Oncology
Volume	190
DOIs	https://doi.org/10.1016/j.radonc.2023.109980
Publication status	Published - Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.radonc.2023.109980

Cite this

Mortensen, H. R., Populaire, P., Hoffmann, L., Moeller, D. S., Appelt, A., Nafteux, P., Muijs, C. T., Grau, C., Hawkins, M. A., Troost, E. G. C., Defraene, G., Canters, R., Clarke, C. S., Weber, D. C., Korevaar, E. W., Haustermans, K., Nordsmark, M., Gebski, V., Achiam, M. P., ... The PROTECT consortium (2024). Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology, 190, Article 109980. https://doi.org/10.1016/j.radonc.2023.109980

@article{ccce9eb2a95b4d6cbb4d557526354dbc,

title = "Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer",

author = "Mortensen, {H. R.} and P. Populaire and L. Hoffmann and Moeller, {D. S.} and A. Appelt and P. Nafteux and Muijs, {C. T.} and C. Grau and Hawkins, {M. A.} and Troost, {E. G.C.} and G. Defraene and R. Canters and Clarke, {C. S.} and Weber, {D. C.} and Korevaar, {E. W.} and K. Haustermans and M. Nordsmark and Val Gebski and Achiam, {M. P.} and Markar, {Sheraz R.} and Ganesh Radhakrishna and Maaike Berbee and Daniele Scartoni and Ester Orlandi and Jerome Doyen and Vincent Gregoire and Gilles Crehange and Johannes Langendijk and Paula Lorgelly and Blommestein, {Hedwig M.} and Byskov, {Camilla S.} and Ehmsen, {Mai L.} and Jensen, {Maria Fuglsang} and Freixas, {Gloria Vilches} and Rebecca B{\"u}toft and {The PROTECT consortium}",

year = "2024",

month = jan,

doi = "10.1016/j.radonc.2023.109980",

language = "English",

volume = "190",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

Mortensen, HR, Populaire, P, Hoffmann, L, Moeller, DS, Appelt, A, Nafteux, P, Muijs, CT, Grau, C, Hawkins, MA, Troost, EGC, Defraene, G, Canters, R, Clarke, CS, Weber, DC, Korevaar, EW, Haustermans, K, Nordsmark, M, Gebski, V, Achiam, MP, Markar, SR, Radhakrishna, G, Berbee, M, Scartoni, D, Orlandi, E, Doyen, J, Gregoire, V, Crehange, G, Langendijk, J, Lorgelly, P, Blommestein, HM, Byskov, CS, Ehmsen, ML, Jensen, MF, Freixas, GV, Bütoft, R & The PROTECT consortium 2024, 'Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer', Radiotherapy and Oncology, vol. 190, 109980. https://doi.org/10.1016/j.radonc.2023.109980

Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. / Mortensen, H. R.; Populaire, P.; Hoffmann, L. et al.
In: Radiotherapy and Oncology, Vol. 190, 109980, 01.2024.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648

T2 - A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

AU - Mortensen, H. R.

AU - Populaire, P.

AU - Hoffmann, L.

AU - Moeller, D. S.

AU - Appelt, A.

AU - Nafteux, P.

AU - Muijs, C. T.

AU - Grau, C.

AU - Hawkins, M. A.

AU - Troost, E. G.C.

AU - Defraene, G.

AU - Canters, R.

AU - Clarke, C. S.

AU - Weber, D. C.

AU - Korevaar, E. W.

AU - Haustermans, K.

AU - Nordsmark, M.

AU - Gebski, Val

AU - Achiam, M. P.

AU - Markar, Sheraz R.

AU - Radhakrishna, Ganesh

AU - Berbee, Maaike

AU - Scartoni, Daniele

AU - Orlandi, Ester

AU - Doyen, Jerome

AU - Gregoire, Vincent

AU - Crehange, Gilles

AU - Langendijk, Johannes

AU - Lorgelly, Paula

AU - Blommestein, Hedwig M.

AU - Byskov, Camilla S.

AU - Ehmsen, Mai L.

AU - Jensen, Maria Fuglsang

AU - Freixas, Gloria Vilches

AU - Bütoft, Rebecca

AU - The PROTECT consortium

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85177493212&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2023.109980

DO - 10.1016/j.radonc.2023.109980

M3 - Editorial

C2 - 37935284

AN - SCOPUS:85177493212

SN - 0167-8140

VL - 190

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

M1 - 109980

ER -

Mortensen HR, Populaire P, Hoffmann L, Moeller DS, Appelt A, Nafteux P et al. Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology. 2024 Jan;190:109980. doi: 10.1016/j.radonc.2023.109980

Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

UN SDGs

Access to Document

Other files and links

Cite this